pharma news today glp-1 obesity drug A new weight-loss pill- Foundayo, is making global headlines, with many claiming it could challenge injectable drugs like Wegovy, Ozempic and Mounjaro. But is that really true?, In this video, we 💊 Millions More Americans Gain

This appetite suppression plays a key role in its ability to promote weight loss , making it an effective option for those struggling with obesity or excess weight

Plateaus are a natural part of any weight loss journey, and its good to plan ahead for them with your doctor

This degree of weight reduction can: Decrease the number of apnea episodes per night Reduce snoring and improve breathing Restore energy and reduce daytime sleepiness TeleMedsForMe Tip: If you have obesity-related sleep apnea, a licensed provider through TeleMedsForMe.com can determine whether GLP-1 therapysuch as Ozempic , Wegovy , or Zepbound is right for you

The GLP-1 market represents a significant business opportunity for digital health solutions that can support behavior change among individuals with obesity and diabetes

2016;311:R124R132

Employees that are managing diabetes at work benefit from education, monitoring tools, and lifestyle interventions that work alongside GLP-1 medications